June 22, 2020 / 11:05 AM / 21 days ago

BRIEF-Aurinia Completes Patient Enrollment Into Audrey Phase 2/3 Clinical Trial Of Voclosporin Ophthalmic Solution

June 22 (Reuters) - Aurinia Pharmaceuticals Inc:

* AURINIA COMPLETES PATIENT ENROLLMENT INTO THE AUDREY PHASE 2/3 CLINICAL TRIAL OF VOCLOSPORIN OPHTHALMIC SOLUTION FOR THE TREATMENT OF DRY EYE SYNDROME

* AURINIA PHARMACEUTICALS INC - VOCLOSPORIN OPHTHALMIC SOLUTION (VOS) RESULTS ANTICIPATED IN Q4 OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below